Home › NDC Lookup › RxCUI directory › RxCUI 1728082

Telavancin 750 MG Injection — RxCUI 1728082

Name: Telavancin 750 MG Injection (RxCUI 1728082)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1728082 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1728082

Official nameTelavancin 750 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known astelavancin (as telavancin hydrochloride) 750 MG Injection

FDA products mapped1

Package NDCs mapped3

Reported Medicaid activity (SDUD)379 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Telavancin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Vibativ only comes as an intravenous infusion — there's no pill or tablet form. It needs to go directly into your bloodstream to reach the high levels needed to fight a serious bac...
Why am I getting this antibiotic through an IV instead of taking a pill?
The most common side effects include an altered or metallic taste, nausea, vomiting, foamy urine, and diarrhea. These are worth mentioning to your care team but aren't usually dang...
What side effects are most likely, and which ones do I need to report right away?

📖 Read our full Telavancin Injection guide →

🕸️ Concept Web — How Telavancin 750 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Telavancin 750 MG Injection RxCUI 1728082 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Telavancin 473837 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vibativ 864628 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Telavancin Injection 1728081 SCDF
- Telavancin Injectable Product 1160886 SCDG
- Telavancin Injection [Vibativ] 1728084 SBDF
- Vibativ Injectable Product 1186243 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Telavancin 750 MG 1728080 SCDC
- Telavancin 750 MG Injection [Vibativ] 1728085 SBD
- Telavancin 750 MG [Vibativ] 1728083 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Telavancin 750 MG SCDC · 1728080
Telavancin Injection SCDF · 1728081
Telavancin Injectable Product SCDG · 1160886

Brand-Name Concepts

Telavancin 750 MG Injection [Vibativ] SBD · 1728085
Telavancin 750 MG [Vibativ] SBDC · 1728083
Telavancin Injection [Vibativ] SBDF · 1728084
Vibativ Injectable Product SBDG · 1186243
Vibativ BN · 864628

📦 FDA Products & Package NDCs

1 product · 3 package NDCs

3 package NDCs map to RxCUI 1728082 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
66220-0315-11	1 VIAL, SINGLE-DOSE in 1 CARTON (66220-315-11) / 50 mL in 1...	VIBATIV	Cumberland Pharmaceuticals Inc.	2021-01-01
66220-0315-22	12 VIAL, SINGLE-DOSE in 1 CARTON (66220-315-22) / 50 mL in...	VIBATIV	Cumberland Pharmaceuticals Inc.	2021-01-01
66220-0315-44	4 VIAL, SINGLE-DOSE in 1 CARTON (66220-315-44) / 50 mL in 1...	VIBATIV	Cumberland Pharmaceuticals Inc.	2023-12-01

Observed labelers: Cumberland Pharmaceuticals Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3095	Telavancin injection	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.